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A B S T R A C T
Background: Idiopathic Rapid eye movement sleep behavior disorder (IRBD) is recognized as the prodromal
stage of the alpha-Synucleinopathies. Although some studies have addressed the characterization of brain
structure in IRBD, little is known about its progression.
Objective: The present work aims at further characterizing gray matter progression throughout IRBD relative to
normal aging and investigating how these changes are associated with cognitive decline.
Methods: Fourteen patients with polysomnography-confirmed IRBD and 18 age-matched healthy controls (HC)
underwent neuropsychological, olfactory, motor, and T1-weighted MRI evaluation at baseline and follow-up. We
compared the evolution of cortical thickness (CTh), subcortical volumes, smell, motor and cognitive perfor-
mance in IRBD and HC after a mean of 1.6 years. FreeSurfer was used for CTh and volumetry preprocessing and
analyses. The symmetrized percent of change (SPC) of the CTh was correlated with the SPC of motor and
neuropsychological performance.
Results: IRBD and HC differed significantly in the cortical thinning progression in regions encompassing bilateral
superior parietal and precuneus, the right cuneus, the left occipital pole and lateral orbitofrontal gyri (FWE
corrected, p < 0.05). The Visual form discrimination test showed worse progression in the IRBD relative to HC,
that was associated with gray matter loss in the right superior parietal and the left precuneus. Increasing motor
signs in IRBD were related to cortical thinning mainly involving frontal regions, and late-onset IRBD was as-
sociated with cortical thinning involving posterior areas (FWE corrected, p < 0.05). Despite finding olfactory
identification deficits in IRBD, results did not show decline over the disease course.
Conclusion: Progression in IRBD patients is characterized by parieto-occipital and orbitofrontal thinning and
visuospatial loss. The cognitive decline in IRBD is associated with degeneration in parietal regions.
1. Introduction
There is growing evidence supporting that idiopathic Rapid eye
movement (REM) sleep behavior disorder (IRBD) is a prodromal
symptom of alpha-Synucleinopathies such as Parkinson’s disease (PD)
and dementia with Lewy bodies (DLB) as well as multiple system
atrophy. A recent multicentric study involving 1280 IRBD patients
found that the overall conversion rate to an overt neurodegenerative
disease was 6.3% per year, with 73.5% converting after 12-year follow-
up (Postuma et al., 2019).
To date, there is a considerable amount of neuroimaging research
showing structural (Campabadal et al., 2019b; De Marzi et al., 2016;
Ehrminger et al., 2016; Ellmore et al., 2010; Hanyu et al., 2012;
Ohlhauser et al., 2019; Park et al., 2018; Pereira et al., 2019;
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Pyatigorskaya et al., 2017; Rahayel et al., 2015; 2018a; 2018b;;
Scherfler et al., 2011; Unger et al., 2010) and functional (Byun et al.,
2020; Campabadal et al., 2020; Dayan and Browner, 2017; Ellmore
et al., 2013; Park et al., 2018; Rolinski et al., 2016) abnormalities in
IRBD patients using MRI. Most importantly, owing to all these works,
there is strong evidence that brain changes relate to cognitive impair-
ment (Byun et al., 2020; Campabadal et al., 2020; Pereira et al., 2019;
Rahayel et al., 2018b; Vendette et al., 2012) and olfactory loss
(Campabadal et al., 2019a; Pereira et al., 2019; Rahayel et al., 2018b;
Vendette et al., 2011). Nevertheless, few researchers have investigated
how the disease progression affects brain structure and function, and
how these changes are associated with cognitive decline. Previous
longitudinal investigations have focused on metabolic prognostic bio-
markers in IRBD. In this sense, reduced dopamine transporter binding
in the striatum (Iranzo et al., 2017), increased hippocampal perfusion
(Dang-Vu et al., 2012), abnormalities in PD related pattern expression
(Holtbernd et al., 2014; Yoon et al., 2019), and hyperechogenicity of
the substantia nigra (Iranzo et al., 2010) were found to be able to
predict phenoconversion in IRBD patients. As for studies focused on
structural progression, a recent work reported that IRBD patients that
eventually convert to Lewy body disease had widespread thinning in
the left superior frontal, right precentral and lateral occipital gyri
compared to non-converters (Pereira et al., 2019). This study found that
converters had widespread cortical loss in frontal, precentral and oc-
cipital regions compared to healthy controls (HC) (Pereira et al., 2019).
However, the lack of MRI follow-up for the control group precludes to
discard the aging effects on brain changes.
Within this framework, the objectives of the current work were (1)
to address differential progressive cortical and subcortical degeneration
between IRBD and normal aging, (2) to study the changes over time in
cognitive functions in IRBD and their relationship with progressive
cortical thinning. We hypothesized that both healthy individuals and
IRBD patients would show an aging-related progressive decline, with
larger degeneration in IRBD given that this parasomnia is considered
part of the prodromal phase of the Synucleinopathies PD and DLB.
2. Material and methods
2.1. Participants
The study sample included 14 patients with IRBD and 18 healthy
subjects who were evaluated at two different time-points by the same
neuropsychologist using the same neuropsychological battery and MRI
scanning protocol. Subjects were evaluated at baseline and after
1.6 ± 0.3 years for patients and 1.6 ± 0.2 years for controls of
follow-up (U = 127; p = 0.97). All participants are part of a long-
itudinal cohort recruited between 2015 and 2017 (Campabadal et al.,
2019b). IRBD patients were recruited from our sleep disorders center
and none of them developed parkinsonism during the follow-up. Di-
agnosis of REM sleep behavior disorder (RBD) required a history of
dream-enacting behaviors, video-polysomnographic demonstration of
REM sleep without atonia, associated with abnormal behaviors, ab-
sence of motor complaints at the time of the recruitment, unremarkable
neurological examination, normal brain magnetic resonance imaging
and no temporal association between the estimated onset of RBD and
the introduction or withdrawal of a medication (Boeve, 2010; Iranzo
et al., 2006). At the time of the current study, eight patients were taking
benzodiazepines to reduce RBD symptomatology. Healthy subjects did
not show sleep disorders, cognitive or motor impairment and were re-
cruited from the Institut de l’Envelliment (Barcelona, Spain).
Exclusion criteria for all participants were: [1] clinical evidence of
movement disorder; [2] presence of psychiatric and/or neurologic co-
morbidity; [3] low global IQ score estimated by the Vocabulary subtest
of the Wechsler Adult Intelligence Scale, 3rd edition (scalar score ≤ 7
points); [4] global cognitive impairment, Mini-Mental State
Examination (MMSE) score < 25, [5] claustrophobia; and [6] MRI
movement artifacts.
The study was approved by the Ethics Committee of the University
of Barcelona (IRB00003099) and Hospital Clinic (HCB/2014/0224). All
subjects provided written informed consent to participate after full
explanation of the procedures involved.
2.2. Neuropsychological assessment
Participants were evaluated with the same neuropsychological
battery at both time points. One IRBD patient and one healthy control
did not complete the neuropsychological assessment, and thus they
were excluded from the analyses that concern these measures.
Attention and working memory were assessed with the Trail Making
Test (TMT, parts A and B) (in seconds), Digit Span Forward and
Backward, the Stroop Color-word Test, and the Symbol Digits
Modalities Test (SDMT)-Oral version. Executive functions were eval-
uated with phonemic (words beginning with the letter “p” in 1 min) and
semantic (animals in 1 min) fluencies. Language was assessed by the
total number of correct responses in the short version of the Boston
Naming Test (BNT). In the memory domain, we assessed the Rey
Auditory Verbal Learning Test total learning recall (sum of correct re-
sponses from trial I to trial V) (RAVLT). Visuospatial and visuo-
perceptual (VS/VP) functions were assessed with Benton’s Judgement
of Line Orientation (BJLO), Visual Form Discrimination (VFD) and
Facial Recognition (FRT) tests (Lezak, 2012).
Expected z scores adjusted for age, sex, and education for each test
and each subject were calculated based on a multiple regression ana-
lysis performed in the HC group (Aarsland et al., 2009). As in a previous
study (Segura et al., 2014), the presence of mild cognitive impairment
(MCI) was established if the z-score for a given test was at least 1.5
lower than the expected score in at least two tests in one domain, or in
at least one test per domain in at least two domains. Mild cognitive
impairment was excluded only for the healthy individuals, but not for
the patients since one of our aims was to study changes over time in
cognitive functions in IRBD, as well as its relationship with cortical
thinning. Furthermore, the presence of dementia was determined if
MMSE score was below 25, or if there was cognitive impairment in
more than one domain and impaired instrumental activities of daily
living (IADL), as recommended by Dubois et al. (Dubois et al., 2007).
Neuropsychiatric symptomatology and instrumental activities of
daily living were measured by means of Beck Depression Inventory II
(BDI) (Beck and Steer1996), Starkstein’s Apathy Scale (AS) (Starkstein
et al., 1992), and the IADL scale.
2.3. MRI acquisition and preprocessing
MRI data were acquired with a 3T scanner (MAGNETOM Trio,
Siemens, Germany) at both times. The scanning protocol included high-
resolution 3-dimensional T1-weighted images acquired in the sagittal
plane (TR = 2300 ms, TE = 2.98 ms, TI = 900 ms, 240 slices,
FOV = 256 mm, 1-mm isotropic voxel) and an axial FLAIR sequence
(TR = 9000 ms, TE = 96 ms).
Cross-sectional preprocessing was performed using the automated
FreeSurfer stream (version 5.1; available at: http://surfer.nmr.harvard.
edu). After processing each subject cross-sectionally, in order to per-
form the longitudinal analyses of the data, within-subject templates
(Reuter and Fischl, 2011) and the corresponding longitudinal files were
created for each time point and subject. Briefly, a template volume for
each subject, using information from all of their time points, and an
average image were created using robust, inverse, consistent registra-
tion (Reuter et al., 2010). All time points were constructed through
unbiased mean images and later aligned. After registration and creation
of the templates, images from all time points were mapped to the
template location and averaged and processed with the default cross-
sectional stream. The symmetrized percent change (SPC) was used for
longitudinal analyses of cortical thickness. Cortical thickness SPC is the
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rate in mm/year with respect to the average thickness [(Thickness at
time point 1 – Thickness at time point 2)/Interval between assess-
ments)]/[0.5*(Thickness at time point 1 + Thickness at time point 2)].
In aging or disease, SPC is expected to be negative in most regions
(https://surfer.nmr.mgh.harvard.edu/fswiki/
LongitudinalTwoStageModel).
Automated subcortical segmentation performed with FreeSurfer was
used to estimate subcortical volumetry. The SPC of subcortical volumes
was computed. Estimated Total Intracranial Volume (eTIV) was ob-
tained to correct volumetric data for inter-individual differences in
brain sizes. Between group differences were assessed in SPC volumetric
data controlled by sex and eTIV.
2.4. Olfactory assessment
Olfactory identification was assessed using the Spanish version of
the University of Pennsylvania Smell Identification Test (UPSIT) (Doty
et al., 1995). Specific exclusion criteria for the olfaction test were: [1]
history of nasal bone fracture, [2] diagnosis of rhinitis or nasal polyps,
and [3] upper respiratory tract infections in the two weeks prior to
testing.
2.5. Motor assessment
Presence of motor symptoms was evaluated using the International
Parkinson and Movement Disorders Society Unified Parkinson's Disease
Rating Scale motor section (MDS-UPDRS-III).
2.6. Statistical analyses
Group differences between HC and IRBD at baseline were analyzed
using Mann-Whitney’s U test and chi-squared test. For longitudinal
neuropsychological and olfactory variables, repeated measures general
linear model was used to assess group differences over time in quan-
titative variables with sex as a covariate. Spearman’s Rho correlations
were used to investigate the relationship between cognitive, clinical
and volumetric data.
Comparisons between groups in the cortical thickness SPC were
performed using a vertex-by-vertex general linear model. Time effects
in both groups and group-by-time interaction effects were computed,
SPC was included as a dependent factor and group as an independent
factor. Regression models included SPC as an independent factor and
clinical or cognitive scores as dependent factors. Sex was introduced as
a covariate in all analyses. Maps were smoothed using a circularly
symmetric Gaussian kernel across the surface with a full width at half
maximum of 15 mm. The vertex-wise cluster threshold was set
at< 0.05. In order to avoid clusters appearing significant purely by
chance (i.e., false positives), Monte Carlo null-Z simulation with 10,000
iterations was applied to cortical thickness maps to provide clusterwise
correction for multiple comparisons. Simulation was applied for nega-
tive time effects (time 2 < time 1) in each group, on all other models,
simulation was applied for absolute results. Results were thresholded at
a corrected p value of 0.05.
3. Results
3.1. Sociodemographic and clinical data
Sociodemographic and clinical data of participants are summarized
in Table 1. No significant differences between groups were found in
age, education and, the interval between assessments. Groups differed
significantly in sex (X2 = 5.039; p = 0.025), as men were more
common in the IRBD group, and for this reason this variable was en-
tered as a covariate in all analyses.
Regarding functional and emotional tests, groups did not differ in
the BDI scale, whereas the IRBD patients had higher scores at baseline
in the AS (U = 188.5; p = 0.02) and lower in the IADL (U = 57.5;
p = 0.01) scales. One IRBD patient reported visual, auditory and tactile
hallucinations. None of the aforementioned scales correlated with
neuropsychological data.
3.2. Neuropsychological, olfactory and motor changes
The longitudinal evolution of cognitive and olfactory performance is
summarized in Table 2. Significant group differences between patients
and HC were found in several measures, namely MMSE, VFD, BJLO,
semantic fluency, RAVLT, Stroop measures, SDMT, TMTA, TMTB and
BNT (see Table 2, for detailed statistical data). Significant group-by-
time interaction was seen in VFD test with worse progression in the
IRBD group relative to HC (F = 12.76; p < 0.001; Hedge’s g effect
size = 1.05 [CI = 0.295–1.845]). Only this test evidenced the clinically
relevant cognitive decline in IRBD. Specifically, 69.2% of the IRBD
patients presented a worsening greater than 1.5 standard deviation in
VFD performance in comparison to baseline scores, while none healthy
individual had such a loss in this test (X2 = 6.036; p = 0.014). Only
one HC, but also one IRBD patient, has worsened greater than −1.5
standard deviation in BNT performance in comparison to baseline
scores (X2 = 0.039; p = 0.687). At follow up, MCI criteria were ful-
filled by 6 (46.2%) patients, from whom 5 were already MCI at base-
line, and one (7.7%) had converted to MCI at follow-up. Olfactory
identification was impaired in IRBD relative to HC (F = 29.4;
p < 0.001), but we did not find decline across time. No significant
time effect was found for the MDS-UPDRS-III for the IRBD group
[baseline 2.9 ± 3.4; follow-up 3.7 ± 3.3 (t = 1.941; p = 0.191)].
3.3. Cortical thickness and subcortical gray matter evolution
Cortical thickness analysis revealed that both groups had significant
progressive GM decline over time (Fig. 1A and Table 3 show the time
effect for each group). In IRBD, cortical thinning was found in both
hemispheres involving mainly the parietal cortices, but also frontal and
occipital regions. Specifically, cortical GM loss was found in the su-
perior and inferior parietal lobes, cuneus, precuneus, precentral and
postcentral gyri, the left lateral occipital and orbitofrontal cortices and
the right rostral middle frontal gyrus (FWE corrected, p-value < 0.05).
In controls, changes were seen in the left pars triangularis, supramar-
ginal gyrus and precuneus. As illustrated in Fig. 1B and Table 3, sig-
nificant group-by-time interactions were found between groups; in
comparison with HC, IRBD patients exhibited significantly greater
progressive cortical thinning encompassing the bilateral superior par-
ietal and precuneus, the right cuneus, the left occipital pole and lateral
Table 1
Demographic and clinical data of the participants.
IRBD (n = 14) HC (n = 18) Test stat/p
Age at baseline, years 70.1 (6.9) 68.3 (7.5) 147/0.44
Education, years 10.1 (5.1) 10.9 (4.2) 101.5/0.36
Sex (male/female) 11/3 7/11 5.039/0.03
IADL scale 6.7 (1.1) 7.5 (1.1) 57.5/0.01
AS scale 13 (5.8) 8 (3.6) 188.5/0.02
BDI scale 5.6 (5.3) 3.8 (3.5) 138.5/0.64
Disease duration 4.5 (3.4) – –
Age of onset 65.6 (7.5) – –
MDS-UPDRS-III 2.9 (3.4) – –
Abbreviations: AS, Starkstein’s Apathy Scale; BDI, Beck Depression Inventory II;
HC, healthy controls; IADL, Lawton and Brody instrumental activities of daily
living scale; IRBD, idiopathic rapid eye movement sleep behavior disorder;
MDS-UPDRS-III, Movement Disorder Society Unified Parkinson’s Disease Rating
Scale motor section. Measures are presented as mean (standard deviation) for
continuous variables. Group differences between HC and IRBD were analyzed
using Mann-Whitney’s U test. Differences in categorical variables were analyzed
with chi-squared test.
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orbitofrontal gyri (FWE corrected, p-value < 0.05). Our results did not
show differences over time between groups in any subcortical volume.
3.4. Clinical and cognitive correlates
To assess the clinical relevance of VFD decline in IRBD patients, we
investigated its structural correlates. Whole-brain analyses showed
significant correlations between changes in VFD over time and cortical
thinning in the right superior parietal and the left precuneus (FWE
corrected, p-value < 0.05) (see Fig. 2 and Table 3). No significant
correlations between VFD changes and cortical thinning was obtained
for the control group.
Changes in the MDS-UPDRS-III over time were associated with
cortical degeneration bilaterally in the superior parietal, the left su-
perior frontal, and right rostral middle frontal (see Fig. 3A and Table 3).
Furthermore, our results highlighted cortical loss in bilateral precuneus
and lateral occipital gyri after 1.6 years in those patients with late onset
of the disease (FWE corrected, p-value < 0.05) (see Fig. 3B and
Table 3).
4. Discussion
In the present study, we aimed to investigate the progression of
cortical and subcortical changes in IRBD relative to healthy individuals,
and how these changes relate to cognitive decline. As far as we know,
this is the first longitudinal work reporting gray matter loss and pro-
gressive worsening in visual discrimination performance in IRBD
compared to normal aging. It is worth noting that structural and cog-
nitive changes are identified even in a short interval of less than two
years.
We found significant group effect in several neuropsychological
tests. Similar to previous studies we identified deficits in verbal learning
(Gagnon et al., 2009; Massicotte-Marquez et al., 2008), semantic flu-
ency (Gagnon et al., 2009; Massicotte-Marquez et al., 2008), mental
processing speed (Pereira et al., 2019), attention and executive func-
tions (Delazer et al., 2012; Ferini-Strambi et al., 2004; Gagnon et al.,
2009; Massicotte-Marquez et al., 2008; Terzaghi et al., 2013). We also
observed impaired VS/VP functions, similarly to the findings in PD and
DLB (Garcia-Diaz et al., 2018a; Mori et al., 2000; Pereira et al., 2009;
Ramírez-Ruiz et al., 2006; Segura et al., 2014; Tiraboschi et al., 2006).
As for the cognitive decline over IRBD, there is still considerable un-
certainty. Previous longitudinal studies including follow-up data for
IRBD and healthy individuals, did not report an interaction between
group and time, so the aging effect could not be ruled out (Fantini et al.,
2011; Terzaghi et al., 2013; Youn et al., 2016). In the current work,
after a short period of time, we found cognitive decline in IRBD relative
to normal aging. Particularly, we identified VFD progressive worsening
with a large effect size, again in agreement with VS/VP findings in PD
and DLB (Garcia-Diaz et al., 2018a; Mori et al., 2000; Pereira et al.,
2009; Ramírez-Ruiz et al., 2006; Segura et al., 2014; Tiraboschi et al.,
2006). Finally, although we found group-by-time interaction for the
BNT, the fact that one HC, but also one IRBD patient, has worsened
greater than −1.5 standard deviation in BNT performance in compar-
ison to baseline scores, calls into question the clinical relevance of this
finding.
MRI data evidenced aging-related structural changes in both groups
with common thinning in the left precuneus and inferior parietal re-
gions but with a larger widespread frontal and parieto-occipital pro-
gression in IRBD. Cortical thickness is a sensitive measure to detect time
effect in normal aging and PD (Uribe et al., 2019), and likewise, it
seems to be useful to track gray matter loss in IRBD patients even in a
short interval of less than two years. Indeed, when we compared both
groups’ cortical thinning pattern across time, we confirmed the larger
degeneration in IRBD relative to healthy individuals bilaterally in the
superior parietal and precuneus, the right cuneus, the left occipital pole
and a cluster involving the left lateral orbitofrontal and frontopolar
cortices. As stated in the introduction, there is no previous research
investigating brain changes in IRBD over time compared to normal
aging. It is interesting noting that already in our cross-sectional study
superior parietal thinning was identified in these patients (Campabadal
et al., 2019b), with our current results, we highlight the involvement of
parietal regions in the progression of IRBD. This predominantly pos-
terior cortical pattern is similar to previous findings in PD and DLB
(Delli Pizzi et al., 2014; Ramírez-Ruiz et al., 2007; Segura et al., 2014;
Uribe et al., 2016).
Cortical degeneration was also observed in left lateral orbitofrontal
and frontopolar cortex. These regions have an important role in com-
plex cognitive processes, namely planning, introspection and problem
solving. In PD, orbitofrontal cortex is associated with decision-making
and recognition of emotions (Ibarretxe-Bilbao et al., 2009). Despite we
Table 2
Neuropsychological decline over time in IRBD and HC.
IRBD (n = 13) HC (n = 17) F (Group) F (Time) F (Group by time)
Baseline Follow-up Baseline Follow-up
MMSE 27.9 (1.7) 28.2 (1.4) 29.4 (1.0) 29.4 (0.6) 10.9/0.003 0.6/0.44 0.3/0.62
VFD 29.3 (2.8) 26.5 (2.3) 29.6 (2.5) 29.5 (2.8) 5.2/0.03 3.9/0.06 12.8/<0.001
BJLO 22.4 (4.9) 22.5 (4.5) 24.1 (3.9) 24.6 (3.8) 4.9/0.04 0.1/0.82 0.1/0.88
FRT Short 21.4 (2.4) 22.1 (3.7) 22.9 (1.9) 23.3 (2.3) 2.3/0.14 0.7/0.42 0.1/0.79
Phonemic fluency 12.9 (5.7) 12.5 (5.1) 16.1 (4.3) 16.3 (4.1) 3.9/0.06 0.3/0.61 0.5/0.49
Semantic fluency 15.0 (5.1) 16.2 (4.9) 19.1 (3.2) 19.1 (2.6) 7.2/0.01 0.8/0.38 0.4/0.54
RAVLT 39.8 (7.2) 41.1 (9.3) 48.7 (7.7) 47.2 (8.2) 6.6/0.02 0.3/0.58 0.6/0.44
Direct Digits 5.3 (1.8) 4.9 (1.1) 5.4 (1.2) 5.3 (0.3) 0.6/0.45 1.2/0.28 0.3/0.64
Indirect Digits 4.2 (0.9) 3.4 (1.1) 4.1 (1.2) 3.9 (1.2) 01.0/0.34 1.0/0.33 3.4/0.08
Stroop W 84.6 (17.6) 81.5 (17.8) 96.3 (14.7) 93.4 (15.7) 8.9/0.01 0.1/0.92 0.6/0.45
Stroop C 54.7 (12.0) 56.2 (13.3) 65.6 (9.5) 60.8 (7.4) 5.2/0.03 0.1/0.81 1.9/0.18
Stroop WC 30.0 (11.3) 29.8 (11.9) 36.5 (9.9) 35.1 (9.6) 4.3/0.05 0.8/0.39 0.4/0.53
SDMT 35.5 (12.6) 35.5 (13.1) 48.1 (9.6) 48.3 (9.8) 11.0/0.003 0.1/0.77 0.1/0.80
TMTA 52.6 (14.1) 54.2 (16.8) 39.4 (17.9) 43.1 (19.3) 15.5/<0.001 2.9/0.09 2.2/0.15
TMTB 161.3 (76.6) 202.2 (102.5) 94.8 (43.2) 126.7 (64.7) 13.8/0.001 4.7/0.04 0.7/0.40
BNT 13.2 (0.9) 13.8 (0.4) 14.1 (0.8) 13.8 (1.2) 4.7/0.04 0.4/0.56 4.7/0.04
UPSIT 17.7 (6.2) 19.2 (6.6) 30.1 (5.6) 30.1 (2.9) 29.4/<0.001 1.2/0.29 0.4/0.53
Abbreviations: BJLO, Benton’s Judgment of Line Orientation test; BNT, Boston Naming Test; FRT Short, Facial Recognition test short form; HC, healthy controls;
IRBD, idiopathic rapid eye movement sleep behavior disorder; MMSE, Mini-mental state examination; RAVLT, Rey’s Auditory Verbal Learning Test sum of correct
responses from trial I to trial V; SDMT, Symbol Digits Modalities Test; Stroop W, Stroop Word; Stroop C, Stroop Color; Stroop WC, Stroop Word-Color; TMTA, Trail
Making Test part A; TMTB, Trail Making Test part B; UPSIT, The University of Pennsylvania Smell Identification Test; VFD, Visual Form Discrimination. Repeated
measures general linear model was used to assess group differences over time with sex as a covariate. Measures are presented as mean (standard deviation).
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found executive dysfunction compared to HC, no decline was found
across time, which might be explained by the fact that the current
neuropsychological assessment did not evaluate specifically orbito-
frontal functions. On the other hand, orbitofrontal regions have also
been associated with olfactory dysfunction in IRBD (Campabadal et al.,
2019a; Pereira et al., 2019) and PD (Ibarretxe-Bilbao et al., 2010).
Nonetheless, despite finding olfactory identification deficits in IRBD
relative to healthy controls, our results did not show decline over the
disease course. In the same line, after a 4-year follow-up, olfactory
decline in IRBD (Iranzo et al., 2013) and PD patients (Campabadal
et al., 2017) was similar to that observed in healthy elder controls.
Iranzo et al. (2013) hypothesized that the absence of longitudinal
changes in IRBD might be explained by a floor effect in olfactory loss
reached at early stages of the disease, suggesting that the smell function
is already compromised in IRBD.
Our study provides new evidence for neuroanatomical substrate of
progressive worsening in IRBD cognition. In particular, we established
that visual discrimination changes over time are related to progressive
reductions in bilateral superior parietal cortical regions. As far as we are
aware, the neuroanatomical basis of cognitive dysfunction in IRBD has
only been studied cross-sectionally (Pereira et al., 2019; Rahayel et al.,
2018b). Specifically, structural mechanisms underpinning VS/VP im-
pairment in IRBD are related with cortical thinning in posterior regions
(Pereira et al., 2019; Rahayel et al., 2018b), but also anterior temporal
(Pereira et al., 2019; Rahayel et al., 2018b) frontal, insular cortices and
with right hippocampal regions (Rahayel et al., 2018b). The involve-
ment of frontal regions in Rahayel et al.’s work, might be explained by
the use of copy drawing and block design to compute VS domain, tasks
that also demand motor and executive functions. It is worth noting that
when assessing specifically VS/VP functions in PD, structural substrates
encompass cortical thinning in lateral temporoparietal regions (Garcia-
Diaz et al., 2018a; 2014). Moreover, as PD progresses, VS/VP impair-
ment is accompanied by bilateral posterior degeneration (Garcia-Diaz
et al., 2018b). Although further longitudinal data with larger samples
are needed to confirm our results, the decline in VS/VP performance
might help to identify those patients presenting progressive neurode-
generation in posterior cortices.
Our results evidenced that in the IRBD group changes in the MDS-
UPDRS-III over time were associated with bilateral cortical degenera-
tion in the superior parietal, and in the left superior frontal, and right
rostral middle frontal. This finding concurs with a previous work where
increasing motor disease severity, measured with the same scale, was
related to cortical thinning in the left superior frontal and fusiform and
the right precentral gyri (Pereira et al., 2019). Interestingly, when
motor output was assessed more thoroughly, slower finger tapping of
the right hand was associated with cortical thinning in the right
Fig. 1. Vertex-wise symmetrized percent change
(SPC) in cortical thickness. A. Time effect for IRBD
and HC group, cold colors represent negative SPC
(GM loss across time); B. Group-by-time interaction,
warm colors depict those regions were IRBD present
reduced SPC in comparison with HC over the course
of the study. Results were obtained using Monte
Carlo simulation with 10,000 iterations applied to
cortical thickness maps to provide cluster-wise cor-
rection for multiple comparisons (FWE corrected, p-
value < 0.05). Simulation was applied for negative
time effects (time 2 < time 1), whereas, on group-
by-time contrast, simulation was applied for abso-
lute results. Sex was used as a covariate.
Abbreviations: HC, healthy controls; IRBD, idio-
pathic REM sleep behavior disorder; L, left; R, right.
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paracentral and superior parietal lobule cortices, and bilaterally with
the pallidum;whereas in the left hand it correlated with cortical thin-
ning in the right postcentral and superior parietal lobule cortices
(Rahayel et al., 2018b). Furthermore, our results highlighted that cor-
tical loss in posterior regions after 1.6 years follow-up was associated
with late-onset IRBD. It is worth noting that in PD, older age at onset is
associated with worse prognosis (Hely et al., 1995), with more severe
motor and nonmotor PD phenotype, and greater impairment of dopa-
minergic dysfunction in the putamen and caudate as measured by
DaTSCAN (Pagano et al., 2016). If we add this to the fact that posterior
cortical degeneration is a well-documented finding of PD and DLB (Delli
Pizzi et al., 2014; Ramírez-Ruiz et al., 2007; Segura et al., 2014; Uribe
et al., 2016), we could speculate that those IRBD with late onset might
presumably present a worse prognosis.
The strengths of our study are that all participants were evaluated
by the same neuropsychologist at both time points, using the same
neuropsychological battery and MRI scanning protocol, thus avoiding
the variability of multicentric data. Moreover, we used a case control-
design to identify different gray matter degeneration in IRBD in com-
parison to normal aging. However, the reduced sample size limits the
generalization of the results, as well as the possibility to further in-
vestigate the sex effect and differences between IRBD with and without
mild cognitive impairment. Another possible limitation of our work is
that some patients were evaluated under the influence of benzodiaze-
pines. Unfortunately, our sample does not allow us to study differences
between medicated and non-medicated patients. On the other hand, the
short time between evaluations may have limited the longitudinal
findings of our work. A longer interval between time points would
allow detecting a decline in other functions. Prospective studies will
help to identify structural and cognitive markers of phenoconversion,
with a particular focus on those able to identify whether a patient will
eventually convert to PD or DLB.
5. Conclusion
The current study gives evidence of progressive cortical degenera-
tion in IRBD mainly encompassing parieto-occipital and orbitofrontal
regions. Additionally, we identified visual discrimination decline over
the course of the disease, and we established its structural substrates,
highlighting the involvement of bilateral parietal cortices in IRBD’s
evolution. Overall, these findings widen our knowledge of how IRBD’s
progression affects brain structure and cognition mainly involving
posterior and orbitofrontal regions, similarly to previous findings in PD
and DLB.
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Table 3
Significant clusters showing cortical thickness differences between groups and
correlations with cognitive and clinical measures
Cluster size
(mm2)







1 17560.6 −17.5 −87.9 19.9 < 0.001 Superior parietal
2 5351.7 −10.7 55.5 −18.7 < 0.001 Lateral
orbitofrontal
3 2248.5 −41.5 −0.3 28.7 0.001 Precentral
RH Clusters
1 1606.7 23.1 60.7 2.2 0.021 Rostral middle
frontal
2 10258.7 7.1 25.7 56.2 < 0.001 Superior frontal
3 7201.8 41.6 −63.6 45.7 < 0.001 Inferior parietal
HC effect Time
LH Clusters
1 1803.3 −47.7 27.9 3.3 0.009 Pars triangularis
2 1615.2 −57.7 −50.2 30.5 0.019 Supramarginal
3 1684.3 −15.0 −44.5 46.5 0.014 Precuneus
Group by Time (IRBD<HC)
LH Clusters
1 5609.7 −17.5 −87.9 19.9 < 0.001 Superior parietal
2 1043.3 −13.4 55.8 −16.7 0.035 Lateral
orbitofrontal
RH Clusters
1 1259.1 20.4 −79.6 43.1 0.012 Superior parietal
Correlation with decline in VFD in IRBD
LH Clusters
1 921.2 −8 −72.6 48.7 0.044 Precuneus
RH Clusters
1 1870.46 21.1 −59.3 58.9 < 0.001 Superior parietal
Correlation with MDS-UPDRS-III changes in IRBD
LH Clusters
1 894.4 −18.9 −3.5 66.3 0.029 Superior frontal
2 999.2 −17.4 −67.5 43.5 0.014 Superior parietal
RH Clusters
1 1494.9 23.6 43.6 31.8 < 0.001 Rostral middle
frontal
2 1770.9 23.4 −61.6 49.3 < 0.001 Superior parietal
Correlation with age of onset in IRBD
LH Clusters
1 4205.8 −42.8 −77.9 2.5 < 0.001 Lateral occipital
2 1658.6 −6.0 −71.3 40.9 < 0.001 Precuneus
3 929.5 −7.8 −98.5 9.4 0.041 Lateral occipital
RH Clusters
1 1676.1 6.8 −44.8 44.1 0.001 Precuneus
Abbreviations: HC, healthy controls; IRBD, idiopathic rapid eye movement
sleep behavior disorder; LH, left hemisphere; MDS-UPDRS-III, Movement
Disorder Society Unified Parkinson’s Disease Rating Scale motor section; RH,
right hemisphere; VFD, Visual Form Discrimination. All analyses are covariated
by sex. Results after FWE correction with Monte Carlo simulation and threshold
at p ≤ 0.05.
Fig. 2. Correlates of VFD changes. Vertex-wise symmetrized percent change
(SPC) in cortical thickness correlations with SPC Visual form Discrimination
(VFD) scores in IRBD group. Sex was used as a covariate. The scale bar shows P
values (FWE corrected, p-value < 0.05).
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